Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ritonavir vs NORVIR Bioequivalence in Healthy Chinese Subjects
NCT03214159Phase 1Completed
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jul 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ritonavir in human immunodeficiency virus infection (HIV), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Maximum Observed Plasma Concentration. Started Jul 2017; status: completed.
02
Drugs
ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03214159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03214159.